Back to results
CompletedPhase 4

Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)

NCT00562172

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sanofi-aventis

Seoul, South Korea

View on ClinicalTrials.gov
Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study) — TrialFind